There were 2,386 press releases posted in the last 24 hours and 440,395 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
Orphan Drug Designation Granted to PTX-252 by U.S. FDA for the Treatment of Acute Myeloid Leukaemia (AML)

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image